sign in sign up
<<
Home , Benzylpiperazine, Nabilone

Federal Register / Vol. 78, No. 35 / Thursday, February 21, 2013 / Notices 12103

Drug Schedule Dated: February 8, 2013. Enforcement Administration (DEA) to Joseph T. Rannazzisi, be registered as a bulk manufacturer of (1585) ...... I Deputy Assistant Administrator, Office of the following basic classes of controlled Alpha-ethyltryptamine (7249) ...... I Diversion Control, Drug Enforcement substances: Lysergic acid diethylamide (7315) I Administration. (7370) ..... I [FR Doc. 2013–03893 Filed 2–20–13; 8:45 am] Drug Schedule 4-Bromo-2,5- I BILLING CODE 4410–09–P (7391). 5-Methoxy-N–N- I 4-Bromo-2,5- I dimethyltryptamine (7431). dimethoxyphenethylamine DEPARTMENT OF JUSTICE –E (2-(2,5-Dimethoxy-4- I (7392). ethylphenyl)ethanamine) (7509). 2,5-Dimethoxyamphetamine I Drug Enforcement Administration 2C–H (2-(2,5- I (7396). Dimethoxyphenyl)ethanamine) 3,4-Methylenedioxyamphetamine I Manufacturer of Controlled (7517). (7400). 2C–T–4 (2-(4-isopropylthio)-2,5- I Substances; Notice of Application; GE dimethoxyphenyl) ethanamine) N-Hydroxy-3,4- I Healthcare (7532). methylenedioxyamphetamine (7402). Pursuant to § 1301.33(a), Title 21 of 3,4-Methylenedioxy-N- I the Code of Federal Regulations (CFR), The company plans to manufacture ethylamphetamine (7404). this is notice that on August 31, 2012, high purity drug standards used for 3,4- I GE Healthcare, 3350 North Ridge analytical applications only in clinical, Methylenedioxymethamphetam- Avenue, Arlington Heights, Illinois toxicological, and forensic laboratories. Any other such applicant, and any ine (MDMA) (7405). 60004–1412, made application by person who is presently registered with (7437) ...... I renewal to the Drug Enforcement DEA to manufacture such substances, 5-Methoxy-N,N- I Administration (DEA) to be registered as (7439). may file comments or objections to the a bulk manufacturer of (9041), 1-[1-(2- I issuance of the proposed registration a basic class of Thienyl)cyclohexyl] pursuant to 21 CFR 1301.33(a). (TCP) (7470). listed in schedule II. Any such written comments or The company plans to manufacture a N- (BZP) (7493) I objections should be addressed, in radioactive product to diagnose (9200) ...... I quintuplicate, to the Drug Enforcement Parkinson’s disease; and to manufacture Normorphine (9313) ...... I Administration, Office of Diversion a bulk investigational new drug (IND) (1100) ...... II Control, Federal Register Representative for clinical trials. (1105) ...... II (ODL), 8701 Morrissette Drive, (7379) ...... II Any other such applicant, and any person who is presently registered with Springfield, Virginia 22152; and must be 1-Phenylcyclohexylamine (7460) II filed no later than April 22, 2013. (7471) ...... II DEA to manufacture such a substance, Dated: February 8, 2013. Cocaine (9041) ...... II may file comments or objections to the (9050) ...... II issuance of the proposed registration Joseph T. Rannazzisi, Ecgonine (9180) ...... II pursuant to 21 CFR 1301.33(a). Deputy Assistant Administrator, Office of (9210) ...... II Any such written comments or Diversion Control, Drug Enforcement (9220) ...... II objections should be addressed, in Administration. Meperidine (9230) ...... II quintuplicate, to the Drug Enforcement [FR Doc. 2013–03919 Filed 2–20–13; 8:45 am] (9240) ...... II Administration, Office of Diversion BILLING CODE 4410–09–P (9250) ...... II Control, Federal Register Representative (9300) ...... II (ODL), 8701 Morrissette Drive, Thebaine (9333) ...... II Springfield, Virginia 22152; and must be DEPARTMENT OF JUSTICE Levo- (9648) .. II filed no later than April 22, 2013. Drug Enforcement Administration (9739) ...... II Dated: February 8, 2013. (9743) ...... II Joseph T. Rannazzisi, Manufacturer of Controlled (9801) ...... II Deputy Assistant Administrator, Office of Substances; Notice of Registration; Diversion Control, Drug Enforcement Cody Laboratories, Inc. The company plans to manufacture Administration. reference standards. [FR Doc. 2013–03895 Filed 2–20–13; 8:45 am] By Notice dated November 1, 2012, BILLING CODE 4410–09–P and published in the Federal Register Any other such applicant, and any on November 9, 2012, 77 FR 67398, person who is presently registered with Cody Laboratories, Inc., ATTN: Richard DEA to manufacture such substances, DEPARTMENT OF JUSTICE Asherman, 601 Yellowstone Avenue, may file comments or objections to the Cody, Wyoming 82414, made issuance of the proposed registration Drug Enforcement Administration application by renewal to the Drug pursuant to 21 CFR 1301.33(a). Enforcement Administration (DEA) to Any such written comments or Manufacturer of Controlled be registered as a bulk manufacturer of Substances, Notice of Application; objections should be addressed, in the following basic classes of controlled Alltech Associates, Inc. quintuplicate, to the Drug Enforcement substances: Administration, Office of Diversion Pursuant to § 1301.33(a), Title 21 of Sched- Control, Federal Register Representative the Code of Federal Regulations (CFR), Drug ule (ODL), 8701 Morrissette Drive, this is notice that on November 19, Springfield, Virginia 22152; and must be 2012, Alltech Associates Inc., 2051 (9145) ...... I filed no later than April 22, 2013. Waukegan Road, Deerfield, Illinois Amphetamine (1100) ...... II 60015, made application to the Drug Methamphetamine (1105) ...... II

VerDate Mar<15>2010 14:47 Feb 20, 2013 Jkt 229001 PO 00000 Frm 00073 Fmt 4703 Sfmt 4703 E:\FR\FM\21FEN1.SGM 21FEN1 erowe on DSK2VPTVN1PROD with NOTICES